Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Sonoma Pharmaceuticals, Inc. (SNOA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.64000.0000 (0.00%)
At close: 04:00PM EST
1.6500 +0.01 (+0.61%)
After hours: 05:28PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.6400
Open1.6200
Bid1.6700 x 1000
Ask1.6700 x 1100
Day's Range1.5889 - 1.7000
52 Week Range1.0000 - 4.2500
Volume233,359
Avg. Volume1,890,524
Market Cap5.094M
Beta (5Y Monthly)1.04
PE Ratio (TTM)N/A
EPS (TTM)-2.4160
Earnings DateFeb 09, 2023 - Feb 13, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SNOA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Sonoma Pharmaceuticals, Inc.
    Analyst Report: Bristol-Myers Squibb CompanyBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
Advertisement
Advertisement